InvestorsHub Logo
Followers 0
Posts 93
Boards Moderated 0
Alias Born 10/02/2013

Re: None

Thursday, 12/01/2016 10:35:50 AM

Thursday, December 01, 2016 10:35:50 AM

Post# of 144814
Bidding War "Yes"

Von Hoff is a giant in pancreatic cancer and is helping PMCB.
Von Hoff was instrumental in helping Celgene, the Company that purchased Abraxis Bioscience for $2.9 Billion!!!!

Abraxis owner Pat Soon-Shiong invented Abraxane. The combination of Abraxane and Gemcitabine increased survival rate by 1.8 months in trials managed by Von Hoff.

PMCB has shown that its CIAB can beat the above therapy considerably. So, PMCB should be valued at at least 3 billion or more. Just saying!!

https://www.google.com/amp/www.forbes.com/sites/matthewherper/2013/01/22/celgenes-abraxane-extends-life-by-1-8-months-in-advanced-pancreatic-cancer/?client=safari
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News